This inventor holds 6 USPTO granted patents and 19 published patent applications and 4 EPO patents. Top assignees: Orna Therapeutics, Inc., Novartis Ag, Sotio Biotech Inc.. Active years: 2024-2025.
Location History:
- Cambridge, MA (US) (2024)
- Quincy, MA (US) (2024)
Company Filing History:
4 out of 12 
1 out of 3,974 
1 out of 1 Years Active: 2024-2025
Title: The Innovative Contributions of Gregory Motz
Introduction
Gregory Motz is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made remarkable advancements in the delivery of therapeutic agents through innovative lipid nanoparticle compositions.
Latest Patents
Among his latest patents, Gregory Motz has developed lipid nanoparticle compositions specifically designed for delivering circular polynucleotides. These novel lipids can be utilized in combination with various lipid components, including helper lipids, structural lipids, and cholesterols. This innovative approach allows for the effective delivery of therapeutic agents, such as nucleic acids, both in vitro and in vivo.
Career Highlights
Throughout his career, Gregory has worked with notable companies in the biotechnology sector, including Orna Therapeutics, Inc. and Sotio Biotech Inc. His work has focused on enhancing the efficacy of therapeutic delivery systems, which has the potential to revolutionize treatment methodologies in various medical fields.
Collaborations
Gregory has collaborated with esteemed colleagues, including Allen T Horhota and Junghoon Yang, contributing to a dynamic exchange of ideas and expertise in his research endeavors.
Conclusion
Gregory Motz's innovative work in lipid nanoparticle compositions exemplifies the impact of dedicated inventors in advancing biotechnology. His contributions continue to pave the way for new therapeutic solutions and enhance the understanding of nucleic acid delivery systems.